Putnam Investments LLC Vincerx Pharma, Inc. Transaction History

Putnam Investments LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.0 - $0.0 $0 - $0	-221,035 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$0.0 - $27.0 $0 - $7.53 Million	-278,965 Reduced 55.79%	221,035 $2.87 Million
Q1 2021 May 17, 2021	BUY	$22.6 - $31.0 $11.3 Million - $15.5 Million	500,000 New	500,000 $9.65 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $4.24M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.